G3BP1 promotes DNA binding and activation of cGAS

G3BP1 promotes DNA binding and activation of cGAS
复制标题

DOI:
10.1038/s41590-018-0262-4
复制
发表时间:
2018
期刊:
Nature Immunology
影响因子:
--
通讯作者:
Xue-Min
Xue-Min
中科院分区:
--
文献类型:
--
作者:
Zhao-Shan Liu;Hong Cai;Wen Xue;Miao Wang;Tian Xia;Wan-Jin Li;Jia-Qing Xing;Ming Zhao;Yi-Jiao Huang;Shuai Chen;Sheng-Ming Wu;Xinzheng Wang;Xin Liu;Xue Pang;Zi-Yu Zhang;Tingting Li;Jiang Dai;Fangting Dong;Qing Xia;Ai-Ling Li;Tao Zhou;Zheng-gang Liu;Xue-Min

文献摘要

相似文献

Cyclic GMP-AMP synthase (cGAS) is a key sensor responsible for cytosolic DNA detection. Here we report that GTPase- activating protein SH3 domain–binding protein 1 (G3BP1) is critical for DNA sensing and efficient activation of cGAS. G3BP1 enhanced DNA binding of cGAS by promoting the formation of large cGAS complexes. G3BP1 deficiency led to inefficient DNA binding by cGAS and inhibited cGAS-dependent interferon (IFN) production. The G3BP1 inhibitor epigallocatechin gal- late (EGCG) disrupted existing G3BP1–cGAS complexes and inhibited DNA-triggered cGAS activation, thereby blocking DNA- induced IFN production both in vivo and in vitro. EGCG administration blunted self DNA–induced autoinflammatory responses in an Aicardi–Goutières syndrome (AGS) mouse model and reduced IFN-stimulated gene expression in cells from a patient with AGS. Thus, our study reveals that G3BP1 physically interacts with and primes cGAS for efficient activation. Furthermore, EGCG- mediated inhibition of G3BP1 provides a potential treatment for cGAS-related autoimmune diseases.